Steven J. Potts, Ph.D., M.B.A.

CEO and Chairman

Flagship Biosciences, LLC

Dr. Potts joined Flagship from Aperio, where he was Vice President of Life Sciences. He managed worldwide sales and marketing in the biopharma segment, where his team achieved global adoption by nearly all of the largest pharmaceutical companies. He defined and led the GLP product development and validation services for the use of whole slide images in regulated preclinical and clinical trials studies, as well as the development of image analysis techniques for angiogenesis. Prior to Aperio, he was Head of Bioinformatics and Biostatistics at Quest Diagnostics Nichols Institute, where his team supported the development of In Vitro Diagnostics Multianalyte Assays (IVDMIA) in oncology and other therapeutic areas. He earned a Ph.D. and M.S. in Biological Engineering, and an MBA from the University of California at Davis, and a B.S. in Physics from Wheaton College, Illinois